The unfolding confrontation between Saba Capital and a swathe of London-listed investment trusts should not be dismissed as just another episode of activist investing. It is something more consequential: a stress test of the UK’s market architecture, and one that is revealing a regulatory blind spot at the heart of
Register for free to keep reading
To continue reading this article and unlock full access to GRIP, register now. You’ll enjoy free access to all content until our subscription service launches in early 2026.
- Unlimited access to industry insights
- Stay on top of key rules and regulatory changes with our Rules Navigator
- Ad-free experience with no distractions
- Regular podcasts from trusted external experts
- Fresh compliance and regulatory content every day